Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda Pharmaceutical Company has announced the establishment of Takeda Shanghai Development Center (TSDC) within its wholly owned subsidiary, Takeda (China) Holdings (TCH).
Subscribe to our email newsletter
Takeda Pharmaceutical (China) Company in Taizhou is responsible for marketing and sales, and Tianjin Takeda Pharmaceuticals in Tianjin is responsible for manufacturing.
Together with Takeda China and Tianjin Takeda, TSDC will work on enhancing the company’s clinical development activities within the Asian region, with a focus on China for general medicine.
The establishment of TSDC will provide a powerful addition to this global development infrastructure, the company said.
Through TSDC, Takeda will continue to conduct high quality clinical trials towards regulatory approval in Asia, with a growing emphasis on China.